The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-benzoyl-3H-benzo[e]indole ID: ALA5273338
Chembl Id: CHEMBL5273338
Max Phase: Preclinical
Molecular Formula: C19H13NO
Molecular Weight: 271.32
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccccc1)c1cc2c(ccc3ccccc32)[nH]1
Standard InChI: InChI=1S/C19H13NO/c21-19(14-7-2-1-3-8-14)18-12-16-15-9-5-4-6-13(15)10-11-17(16)20-18/h1-12,20H
Standard InChI Key: RGRNKAPBCROJME-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 271.32Molecular Weight (Monoisotopic): 271.0997AlogP: 4.55#Rotatable Bonds: 2Polar Surface Area: 32.86Molecular Species: NEUTRALHBA: 1HBD: 1#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.34CX Basic pKa: ┄CX LogP: 4.44CX LogD: 4.44Aromatic Rings: 4Heavy Atoms: 21QED Weighted: 0.53Np Likeness Score: -0.34
References 1. Wang Y, Qu C, Liu T, Wang C.. (2020) PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationships., 203 [PMID:32679452 ] [10.1016/j.ejmech.2020.112612 ]